hello everyone, I am new in using BWA and samtools, but I found something really strange: I used two different parameter settings of BWA for mapping, and I got two mapping results. Then I used samtools to call SNP from the two mapping results respectively, got SNP collection A and B. a SNP X presents in A while absent in B. But the real problem is: when I browsered the mapping results with "samtools tview", I found the locus X is a real SNP in both mapping results! So my problem is : the BWA parameter did not affected mapping results, but affected snp calling with samtools!
-
-
appreciaton
all replies are greatly appreciated! -
It's unlikely that the parameters you feed to bwa would change the results of SNP calling without also resulting in different mapping. In the case that you're describing, was there a difference in depth at the position in question between the SAM files? That would seem to be the most likely cause.Comment
-
Thanks!~ I have checked the depth at the locus on both mapping results, one is 241, the other 243. So it is unlikely to be the reason....Originally posted by dpryan View PostComment
-
OK, I got it, finally~~ when I applied -BE when calling variants with the bcftools, the missing locus could be detected again. Inspired by this post: http://seqanswers.com/forums/showthread.php?t=16786.Comment
-
i also meet the same problem! may i have a chat with you? hellohenry.my email:[email protected] QQ:872664567Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment